A physician with nearly two decades of experience, Natasha Tiffany, MD, treats patients through a private hematology and oncology practice in Salem, Oregon. Throughout her career, Natasha Tiffany, MD, has been an active member of the greater medical community. She participates in several professional organizations and gives talks regularly on a variety of topics, including those related to the latest treatments and trends in breast cancer. According to an October 2017 report from the American Cancer Society, breast cancer deaths declined by nearly 40 percent between 1989 and 2015. The decline equates to 322,600 deaths that were averted during that 26-year period. The report attributes the decline to advancements that have been made in the detection and treatment of breast cancer. These include mammography, improved chemotherapy regimens, and drugs such as tamoxifen and Herceptin. Despite the reduction in breast cancer deaths, however, the disease still accounts for many thousands of deaths each year and racial disparities still exist among patients. It is the most common cancer diagnosis in women in the United States and the second leading of cancer deaths in the country. According to the American Cancer Society, approximately 1 in 8 women in the United States will be diagnosed with breast cancer during their lifetimes.
0 Comments
Leave a Reply. |
AuthorNatasha Tiffany, MD, is a physician, educator, and research scientist currently working in Oregon. A Partner and Physician in a private practice located in the state’s capital city of Salem, Dr. Tiffany teaches at her alma mater, Oregon Health & Science University, where she is an Affiliate Assistant Professor in the Hematology and Medical Oncology Division. Archives
October 2019
Categories
All
|